▶ 調査レポート

世界の転移性骨がん市場：市場規模・現状・予測
• 英文タイトル：Global Metastatic Bones Cancer Market Size, Status and Forecast 2019-2025

QYResearchが調査・発行した産業分析レポートです。世界の転移性骨がん市場：市場規模・現状・予測 / Global Metastatic Bones Cancer Market Size, Status and Forecast 2019-2025 / QYR9N7551資料のイメージです。• レポートコード：QYR9N7551
• 出版社/出版日：QYResearch / 2019年6月14日
※2024年版があります。お問い合わせください。
• レポート形態：英文、PDF、94ページ
• 納品方法：Eメール（受注後２～3営業日）
• 産業分類：医療・製薬・バイオ
• 販売価格（消費税別）
  Single User￥577,200 (USD3,900)▷ お問い合わせ
  Enterprise License￥1,154,400 (USD7,800)▷ お問い合わせ
• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
当資料は、転移性骨がんのグローバル市場について調査・分析したレポートで、種類別（）、用途別（）、主要地域別（アメリカ、ヨーロッパ、中国、日本、東南アジア、インド、中南米）の市場規模、市場予測、関連企業情報などが含まれています。

・転移性骨がんの世界市場規模
・主要企業別市場シェア
・転移性骨がんの世界市場規模：種類別（）
・転移性骨がんの世界市場規模：用途別（）
・転移性骨がんのアメリカ市場規模（種類別、用途別）
・転移性骨がんのヨーロッパ市場規模（種類別、用途別）
・転移性骨がんの中国市場規模（種類別、用途別）
・転移性骨がんの日本市場規模（種類別、用途別）
・転移性骨がんの東南アジア市場規模（種類別、用途別）
・転移性骨がんのインド市場規模（種類別、用途別）
・転移性骨がんの中南米市場規模（種類別、用途別）
・主要企業別分析（企業概要、製品動向、販売量など）
・転移性骨がんの世界市場予測（2019年-2025年）
・転移性骨がんの地域別市場予測（2019年-2025年）
...

Bone metastasis occurs when cancer cells spread from their original site to a bone. Nearly all types ofcancer can spread (metastasize) to the bones. But some types of cancer are particularly likely to spread to bone, including breast cancer and prostatecancerIn 2018, the global Metastatic Bones Cancer market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025.

This report focuses on the global Metastatic Bones Cancer status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Metastatic Bones Cancer development in United States, Europe and China.

The key players covered in this study
Amgen
Merck & Co
Roche
Novartis
Eli Lilly and Company
Bayer
Fresenius Kabi
BTG plc
Boston Scientific
Medtronic

Market segment by Type, the product can be split into
Medication
Radiation Therapy
Surgical Intervention
Tumor Ablation Therapy

Market segment by Application, split into
Hospitals
Clinics
Others

Market segment by Regions/Countries, this report covers
United States
Europe
China
Japan
Southeast Asia
India
Central & South America

The study objectives of this report are:
To analyze global Metastatic Bones Cancer status, future forecast, growth opportunity, key market and key players.
To present the Metastatic Bones Cancer development in United States, Europe and China.
To strategically profile the key players and comprehensively analyze their development plan and strategies.
To define, describe and forecast the market by product type, market and key regions.

In this study, the years considered to estimate the market size of Metastatic Bones Cancer are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

レポート目次

Table of Contents

1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered
1.4 Market Analysis by Type
1.4.1 Global Metastatic Bones Cancer Market Size Growth Rate by Type (2014-2025)
1.4.2 Medication
1.4.3 Radiation Therapy
1.4.4 Surgical Intervention
1.4.5 Tumor Ablation Therapy
1.5 Market by Application
1.5.1 Global Metastatic Bones Cancer Market Share by Application (2014-2025)
1.5.2 Hospitals
1.5.3 Clinics
1.5.4 Others
1.6 Study Objectives
1.7 Years Considered

2 Global Growth Trends
2.1 Metastatic Bones Cancer Market Size
2.2 Metastatic Bones Cancer Growth Trends by Regions
2.2.1 Metastatic Bones Cancer Market Size by Regions (2014-2025)
2.2.2 Metastatic Bones Cancer Market Share by Regions (2014-2019)
2.3 Industry Trends
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Opportunities

3 Market Share by Key Players
3.1 Metastatic Bones Cancer Market Size by Manufacturers
3.1.1 Global Metastatic Bones Cancer Revenue by Manufacturers (2014-2019)
3.1.2 Global Metastatic Bones Cancer Revenue Market Share by Manufacturers (2014-2019)
3.1.3 Global Metastatic Bones Cancer Market Concentration Ratio (CR5 and HHI)
3.2 Metastatic Bones Cancer Key Players Head office and Area Served
3.3 Key Players Metastatic Bones Cancer Product/Solution/Service
3.4 Date of Enter into Metastatic Bones Cancer Market
3.5 Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Type and Application
4.1 Global Metastatic Bones Cancer Market Size by Type (2014-2019)
4.2 Global Metastatic Bones Cancer Market Size by Application (2014-2019)

5 United States
5.1 United States Metastatic Bones Cancer Market Size (2014-2019)
5.2 Metastatic Bones Cancer Key Players in United States
5.3 United States Metastatic Bones Cancer Market Size by Type
5.4 United States Metastatic Bones Cancer Market Size by Application

6 Europe
6.1 Europe Metastatic Bones Cancer Market Size (2014-2019)
6.2 Metastatic Bones Cancer Key Players in Europe
6.3 Europe Metastatic Bones Cancer Market Size by Type
6.4 Europe Metastatic Bones Cancer Market Size by Application

7 China
7.1 China Metastatic Bones Cancer Market Size (2014-2019)
7.2 Metastatic Bones Cancer Key Players in China
7.3 China Metastatic Bones Cancer Market Size by Type
7.4 China Metastatic Bones Cancer Market Size by Application

8 Japan
8.1 Japan Metastatic Bones Cancer Market Size (2014-2019)
8.2 Metastatic Bones Cancer Key Players in Japan
8.3 Japan Metastatic Bones Cancer Market Size by Type
8.4 Japan Metastatic Bones Cancer Market Size by Application

9 Southeast Asia
9.1 Southeast Asia Metastatic Bones Cancer Market Size (2014-2019)
9.2 Metastatic Bones Cancer Key Players in Southeast Asia
9.3 Southeast Asia Metastatic Bones Cancer Market Size by Type
9.4 Southeast Asia Metastatic Bones Cancer Market Size by Application

10 India
10.1 India Metastatic Bones Cancer Market Size (2014-2019)
10.2 Metastatic Bones Cancer Key Players in India
10.3 India Metastatic Bones Cancer Market Size by Type
10.4 India Metastatic Bones Cancer Market Size by Application

11 Central & South America
11.1 Central & South America Metastatic Bones Cancer Market Size (2014-2019)
11.2 Metastatic Bones Cancer Key Players in Central & South America
11.3 Central & South America Metastatic Bones Cancer Market Size by Type
11.4 Central & South America Metastatic Bones Cancer Market Size by Application

12 International Players Profiles
12.1 Amgen
12.1.1 Amgen Company Details
12.1.2 Company Description and Business Overview
12.1.3 Metastatic Bones Cancer Introduction
12.1.4 Amgen Revenue in Metastatic Bones Cancer Business (2014-2019)
12.1.5 Amgen Recent Development
12.2 Merck & Co
12.2.1 Merck & Co Company Details
12.2.2 Company Description and Business Overview
12.2.3 Metastatic Bones Cancer Introduction
12.2.4 Merck & Co Revenue in Metastatic Bones Cancer Business (2014-2019)
12.2.5 Merck & Co Recent Development
12.3 Roche
12.3.1 Roche Company Details
12.3.2 Company Description and Business Overview
12.3.3 Metastatic Bones Cancer Introduction
12.3.4 Roche Revenue in Metastatic Bones Cancer Business (2014-2019)
12.3.5 Roche Recent Development
12.4 Novartis
12.4.1 Novartis Company Details
12.4.2 Company Description and Business Overview
12.4.3 Metastatic Bones Cancer Introduction
12.4.4 Novartis Revenue in Metastatic Bones Cancer Business (2014-2019)
12.4.5 Novartis Recent Development
12.5 Eli Lilly and Company
12.5.1 Eli Lilly and Company Company Details
12.5.2 Company Description and Business Overview
12.5.3 Metastatic Bones Cancer Introduction
12.5.4 Eli Lilly and Company Revenue in Metastatic Bones Cancer Business (2014-2019)
12.5.5 Eli Lilly and Company Recent Development
12.6 Bayer
12.6.1 Bayer Company Details
12.6.2 Company Description and Business Overview
12.6.3 Metastatic Bones Cancer Introduction
12.6.4 Bayer Revenue in Metastatic Bones Cancer Business (2014-2019)
12.6.5 Bayer Recent Development
12.7 Fresenius Kabi
12.7.1 Fresenius Kabi Company Details
12.7.2 Company Description and Business Overview
12.7.3 Metastatic Bones Cancer Introduction
12.7.4 Fresenius Kabi Revenue in Metastatic Bones Cancer Business (2014-2019)
12.7.5 Fresenius Kabi Recent Development
12.8 BTG plc
12.8.1 BTG plc Company Details
12.8.2 Company Description and Business Overview
12.8.3 Metastatic Bones Cancer Introduction
12.8.4 BTG plc Revenue in Metastatic Bones Cancer Business (2014-2019)
12.8.5 BTG plc Recent Development
12.9 Boston Scientific
12.9.1 Boston Scientific Company Details
12.9.2 Company Description and Business Overview
12.9.3 Metastatic Bones Cancer Introduction
12.9.4 Boston Scientific Revenue in Metastatic Bones Cancer Business (2014-2019)
12.9.5 Boston Scientific Recent Development
12.10 Medtronic
12.10.1 Medtronic Company Details
12.10.2 Company Description and Business Overview
12.10.3 Metastatic Bones Cancer Introduction
12.10.4 Medtronic Revenue in Metastatic Bones Cancer Business (2014-2019)
12.10.5 Medtronic Recent Development

13 Market Forecast 2019-2025
13.1 Market Size Forecast by Regions
13.2 United States
13.3 Europe
13.4 China
13.5 Japan
13.6 Southeast Asia
13.7 India
13.8 Central & South America
13.9 Market Size Forecast by Product (2019-2025)
13.10 Market Size Forecast by Application (2019-2025)

14 Analyst’s Viewpoints/Conclusions

15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
12.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Disclaimer
15.3 Author Details

List of Tables and Figures

Table Metastatic Bones Cancer Key Market Segments
Table Key Players Metastatic Bones Cancer Covered
Table Global Metastatic Bones Cancer Market Size Growth Rate by Type 2014-2025 (Million US$)
Figure Global Metastatic Bones Cancer Market Size Market Share by Type 2014-2025
Figure Medication Figures
Table Key Players of Medication
Figure Radiation Therapy Figures
Table Key Players of Radiation Therapy
Figure Surgical Intervention Figures
Table Key Players of Surgical Intervention
Figure Tumor Ablation Therapy Figures
Table Key Players of Tumor Ablation Therapy
Table Global Metastatic Bones Cancer Market Size Growth by Application 2014-2025 (Million US$)
Figure Hospitals Case Studies
Figure Clinics Case Studies
Figure Others Case Studies
Figure Metastatic Bones Cancer Report Years Considered
Table Global Metastatic Bones Cancer Market Size 2014-2025 (Million US$)
Figure Global Metastatic Bones Cancer Market Size and Growth Rate 2014-2025 (Million US$)
Table Global Metastatic Bones Cancer Market Size by Regions 2014-2025 (Million US$)
Table Global Metastatic Bones Cancer Market Size by Regions 2014-2019 (Million US$)
Table Global Metastatic Bones Cancer Market Share by Regions 2014-2019
Figure Global Metastatic Bones Cancer Market Share by Regions 2014-2019
Figure Global Metastatic Bones Cancer Market Share by Regions 2019
Table Market Top Trends
Table Global Metastatic Bones Cancer Revenue by Manufacturers (2014-2019) (Million US$)
Table Global Metastatic Bones Cancer Market Share by Manufacturers (2014-2019)
Figure Global Metastatic Bones Cancer Market Share by Manufacturers in 2018
Table Global Metastatic Bones Cancer Manufacturers Market Concentration Ratio (CR5 and HHI)
Table Key Players Head office and Area Served
Table Key Players Metastatic Bones Cancer Product/Solution/Service
Table Date of Enter into Metastatic Bones Cancer Market
Table Mergers & Acquisitions, Expansion Plans
Table Global Metastatic Bones Cancer Market Size by Type (2014-2019) (Million US$)
Table Global Metastatic Bones Cancer Market Size Share by Type (2014-2019)
Figure Global Metastatic Bones Cancer Market Size Market Share by Type (2014-2019)
Table Global Metastatic Bones Cancer Market Size by Application (2014-2019) (Million US$)
Table Global Metastatic Bones Cancer Market Size Share by Application (2014-2019)
Figure Global Metastatic Bones Cancer Market Size Market Share by Application (2014-2019)
Figure Global Metastatic Bones Cancer Revenue Market Share by Application in 2018
Figure United States Metastatic Bones Cancer Market Size 2014-2019 (Million US$)
Table United States Key Players Metastatic Bones Cancer Revenue (2018-2019) (Million US$)
Table United States Key Players Metastatic Bones Cancer Market Share (2018-2019)
Table United States Metastatic Bones Cancer Market Size by Type (2014-2019) (Million US$)
Table United States Metastatic Bones Cancer Market Share by Type (2014-2019)
Table United States Metastatic Bones Cancer Market Size by Application (2014-2019) (Million US$)
Table United States Metastatic Bones Cancer Market Share by Application (2014-2019)
Figure Europe Metastatic Bones Cancer Market Size 2014-2019 (Million US$)
Table Europe Key Players Metastatic Bones Cancer Revenue (2018-2019) (Million US$)
Table Europe Key Players Metastatic Bones Cancer Market Share (2018-2019)
Table Europe Metastatic Bones Cancer Market Size by Type (2014-2019) (Million US$)
Table Europe Metastatic Bones Cancer Market Share by Type (2014-2019)
Table Europe Metastatic Bones Cancer Market Size by Application (2014-2019) (Million US$)
Table Europe Metastatic Bones Cancer Market Share by Application (2014-2019)
Figure China Metastatic Bones Cancer Market Size 2014-2019 (Million US$)
Table China Key Players Metastatic Bones Cancer Revenue (2018-2019) (Million US$)
Table China Key Players Metastatic Bones Cancer Market Share (2018-2019)
Table China Metastatic Bones Cancer Market Size by Type (2014-20189) (Million US$)
Table China Metastatic Bones Cancer Market Share by Type (2014-2019)
Table China Metastatic Bones Cancer Market Size by Application (2014-2019) (Million US$)
Table China Metastatic Bones Cancer Market Share by Application (2014-2019)
Figure Japan Metastatic Bones Cancer Market Size 2014-2019 (Million US$)
Table Japan Key Players Metastatic Bones Cancer Revenue (2018-2019) (Million US$)
Table Japan Key Players Metastatic Bones Cancer Market Share (2018-2019)
Table Japan Metastatic Bones Cancer Market Size by Type (2014-2019) (Million US$)
Table Japan Metastatic Bones Cancer Market Share by Type (2014-2019)
Table Japan Metastatic Bones Cancer Market Size by Application (2014-2019) (Million US$)
Table Japan Metastatic Bones Cancer Market Share by Application (2014-2019)
Figure Southeast Asia Metastatic Bones Cancer Market Size 2014-2019 (Million US$)
Table Southeast Asia Key Players Metastatic Bones Cancer Revenue (2018-2019) (Million US$)
Table Southeast Asia Key Players Metastatic Bones Cancer Market Share (2018-2019)
Table Southeast Asia Metastatic Bones Cancer Market Size by Type (2014-2019) (Million US$)
Table Southeast Asia Metastatic Bones Cancer Market Share by Type (2014-2019)
Table Southeast Asia Metastatic Bones Cancer Market Size by Application (2014-2019) (Million US$)
Table Southeast Asia Metastatic Bones Cancer Market Share by Application (2014-2019)
Figure India Metastatic Bones Cancer Market Size 2014-2019 (Million US$)
Table India Key Players Metastatic Bones Cancer Revenue (2018-2019) (Million US$)
Table India Key Players Metastatic Bones Cancer Market Share (2018-2019)
Table India Metastatic Bones Cancer Market Size by Type (2014-2019) (Million US$)
Table India Metastatic Bones Cancer Market Share by Type (2014-2019)
Table India Metastatic Bones Cancer Market Size by Application (2014-2019) (Million US$)
Table India Metastatic Bones Cancer Market Share by Application (2014-2019)
Figure Central & South America Metastatic Bones Cancer Market Size 2014-2019 (Million US$)
Table Central & South America Key Players Metastatic Bones Cancer Revenue (2018-2019) (Million US$)
Table Central & South America Key Players Metastatic Bones Cancer Market Share (2018-2019)
Table Central & South America Metastatic Bones Cancer Market Size by Type (2014-2019) (Million US$)
Table Central & South America Metastatic Bones Cancer Market Share by Type (2014-2019)
Table Central & South America Metastatic Bones Cancer Market Size by Application (2014-2019) (Million US$)
Table Central & South America Metastatic Bones Cancer Market Share by Application (2014-2019)
Table Amgen Company Details
Table Amgen Revenue in Metastatic Bones Cancer Business (2014-2019) (Million US$)
Figure Amgen Revenue Growth Rate in Metastatic Bones Cancer Business (2014-2019)
Table Amgen Recent Development
Table Merck & Co Company Details
Table Merck & Co Revenue in Metastatic Bones Cancer Business (2014-2019)(Million US$)
Figure Merck & Co Revenue Growth Rate in Metastatic Bones Cancer Business (2014-2019)
Table Merck & Co Recent Development
Table Roche Company Details
Table Roche Revenue in Metastatic Bones Cancer Business (2014-2019)(Million US$)
Figure Roche Revenue Growth Rate in Metastatic Bones Cancer Business (2014-2019)
Table Roche Recent Development
Table Novartis Company Details
Table Novartis Revenue in Metastatic Bones Cancer Business (2014-2019)(Million US$)
Figure Novartis Revenue Growth Rate in Metastatic Bones Cancer Business (2014-2019)
Table Novartis Recent Development
Table Eli Lilly and Company Company Details
Table Eli Lilly and Company Revenue in Metastatic Bones Cancer Business (2014-2019)(Million US$)
Figure Eli Lilly and Company Revenue Growth Rate in Metastatic Bones Cancer Business (2014-2019)
Table Eli Lilly and Company Recent Development
Table Bayer Company Details
Table Bayer Revenue in Metastatic Bones Cancer Business (2014-2019)(Million US$)
Figure Bayer Revenue Growth Rate in Metastatic Bones Cancer Business (2014-2019)
Table Bayer Recent Development
Table Fresenius Kabi Company Details
Table Fresenius Kabi Revenue in Metastatic Bones Cancer Business (2014-2019)(Million US$)
Figure Fresenius Kabi Revenue Growth Rate in Metastatic Bones Cancer Business (2014-2019)
Table Fresenius Kabi Recent Development
Table BTG plc Company Details
Table BTG plc Revenue in Metastatic Bones Cancer Business (2014-2019)(Million US$)
Figure BTG plc Revenue Growth Rate in Metastatic Bones Cancer Business (2014-2019)
Table BTG plc Recent Development
Table Boston Scientific Company Details
Table Boston Scientific Revenue in Metastatic Bones Cancer Business (2014-2019)(Million US$)
Figure Boston Scientific Revenue Growth Rate in Metastatic Bones Cancer Business (2014-2019)
Table Boston Scientific Recent Development
Table Medtronic Company Details
Table Medtronic Revenue in Metastatic Bones Cancer Business (2014-2019)(Million US$)
Figure Medtronic Revenue Growth Rate in Metastatic Bones Cancer Business (2014-2019)
Table Medtronic Recent Development
Table Global Metastatic Bones Cancer Market Size by Regions (Million US$) 2019-2025
Figure Global Metastatic Bones Cancer Market Size Share by Regions (2019-2025)
Figure Global Metastatic Bones Cancer Market Size Share by Regions in 2025
Figure United States Metastatic Bones Cancer Market Size Forecast (2019-2025)(Million USD)
Figure Europe Metastatic Bones Cancer Market Size Forecast (2019-2025)(Million USD)
Figure China Metastatic Bones Cancer Market Size Forecast (2019-2025)(Million USD)
Figure Japan Metastatic Bones Cancer Market Size Forecast (2019-2025)(Million USD)
Figure Southeast Asia Metastatic Bones Cancer Market Size Forecast (2019-2025)(Million USD)
Figure India Metastatic Bones Cancer Market Size Forecast (2019-2025)(Million USD)
Figure Central & South America Metastatic Bones Cancer Market Size Forecast (2019-2025)(Million USD)
Table Global Metastatic Bones Cancer Market Size by Product (2019-2025) (Million US$)
Figure Global Metastatic Bones Cancer Market Size by Product (2019-2025)
Figure Global Metastatic Bones Cancer Market Size by Product in 2025
Table Global Metastatic Bones Cancer Market Size by Application (2019-2025) (Million US$)
Figure Global Metastatic Bones Cancer Market Size by Application (2019-2025)
Figure Global Metastatic Bones Cancer Market Size by Application in 2025
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources

以下、関連資料のご紹介
  • 世界の転移性骨がんの薬物治療市場：市場規模・現状・予測
    Global Metastatic Bones Cancer Medication Treatment Market Size, Status and Forecast 2019-2025
    QYR9N7552 2019年6月14日 95Pages
    当資料は、転移性骨がんの薬物治療のグローバル市場について調査・分析したレポートで、種類別（）、用途別（）、主要地域別（アメリカ、ヨーロッパ、中国、日本、東南アジア、インド、中南米）の市場規模、市場予測、関連企業情報などが含まれています。

    ・転移性骨がんの薬物治療の世界市場規...
  • 世界の転移性乳がんの治療市場：市場規模・現状・予測
    Global Metastatic Breast Cancer Treatment Market Size, Status and Forecast 2019-2025
    QYR9N7553 2019年6月14日 96Pages
    当資料は、転移性乳がんの治療のグローバル市場について調査・分析したレポートで、種類別（化学療法、放射線療法、生物学的標的療法、乳房手術、ホルモン療法）、用途別（病院、診療所、その他）、主要地域別（アメリカ、ヨーロッパ、中国、日本、東南アジア、インド、中南米）の市場規模、市場予測、関連企業情報などが含...
  • 世界の転移性大腸がんの治療市場：市場規模・現状・予測
    Global Metastatic Colorectal Cancer Treatment Market Size, Status and Forecast 2019-2025
    QYR9N7555 2019年6月14日 95Pages
    当資料は、転移性大腸がんの治療のグローバル市場について調査・分析したレポートで、種類別（手術、化学療法）、用途別（病院、診療所、がん研究センター）、主要地域別（アメリカ、ヨーロッパ、中国、日本、東南アジア、インド、中南米）の市場規模、市場予測、関連企業情報などが含まれています。

  • 世界の転移性結腸直腸がん手術市場：市場規模・現状・予測
    Global Metastatic Colorectal Cancer Surgery Market Size, Status and Forecast 2019-2025
    QYR9N7554 2019年6月14日 98Pages
    当資料は、転移性結腸直腸がん手術のグローバル市場について調査・分析したレポートで、種類別（腫瘍の切除、門脈塞栓術）、用途別（病院、診療所、がん研究センター）、主要地域別（アメリカ、ヨーロッパ、中国、日本、東南アジア、インド、中南米）の市場規模、市場予測、関連企業情報などが含まれています。
    ...
  • 世界の転移性骨疾患市場：市場規模・現状・予測
    Global Metastatic Bone Disease Market Size, Status and Forecast 2019-2025
    QYR9N7550 2019年6月14日 96Pages
    当資料は、転移性骨疾患のグローバル市場について調査・分析したレポートで、種類別（）、用途別（）、主要地域別（アメリカ、ヨーロッパ、中国、日本、東南アジア、インド、中南米）の市場規模、市場予測、関連企業情報などが含まれています。

    ・転移性骨疾患の世界市場規模
    ・主...
  • 世界の転移性骨疾患の治療市場：市場規模・現状・予測
    Global Medication Treatment of Metastatic Bone Disease Market Size, Status and Forecast 2019-2025
    QYR9N7531 2019年6月14日 93Pages
    当資料は、転移性骨疾患の治療のグローバル市場について調査・分析したレポートで、種類別（）、用途別（）、主要地域別（アメリカ、ヨーロッパ、中国、日本、東南アジア、インド、中南米）の市場規模、市場予測、関連企業情報などが含まれています。

    ・転移性骨疾患の治療の世界市場規模
  • 世界の上咽頭がん市場：市場規模・現状・予測
    Global Nasopharyngeal Cancer Market Size, Status and Forecast 2019-2025
    QYR9N7629 2019年6月14日 98Pages
    当資料は、上咽頭がんのグローバル市場について調査・分析したレポートで、種類別（手術、放射線、化学療法）、用途別（病院、診療所、がん治療とリハビリセンター）、主要地域別（アメリカ、ヨーロッパ、中国、日本、東南アジア、インド、中南米）の市場規模、市場予測、関連企業情報などが含まれています。
    ...
  • 世界の肺がん市場：市場規模・現状・予測
    Global Lung Cancer Market Size, Status and Forecast 2019-2025
    QYR9N7482 2019年6月14日 96Pages
    当資料は、肺がんのグローバル市場について調査・分析したレポートで、種類別（SCLC肺がん、NSCLC肺がん）、用途別（病院と診療所、がん研究センター、実験室）、主要地域別（アメリカ、ヨーロッパ、中国、日本、東南アジア、インド、中南米）の市場規模、市場予測、関連企業情報などが含まれています。
  • 世界の黒色腫がん市場：市場規模・現状・予測
    Global Melanoma Cancer Market Size, Status and Forecast 2019-2025
    QYR9N7533 2019年6月14日 96Pages
    当資料は、黒色腫がんのグローバル市場について調査・分析したレポートで、種類別（非侵襲性黒色腫、浸潤性黒色腫）、用途別（病院、がん研究センター）、主要地域別（アメリカ、ヨーロッパ、中国、日本、東南アジア、インド、中南米）の市場規模、市場予測、関連企業情報などが含まれています。

    ...
  • 世界の非侵襲がん診断市場：市場規模・現状・予測
    Global Non-invasive Cancer Diagnosis Market Size, Status and Forecast 2019-2025
    QYR9N7685 2019年6月14日 91Pages
    当資料は、非侵襲がん診断のグローバル市場について調査・分析したレポートで、種類別（臨床化学、免疫化学/イムノアッセイ、分子診断、その他）、用途別（血液がん、固形腫瘍、乳がん、肺癌、その他）、主要地域別（アメリカ、ヨーロッパ、中国、日本、東南アジア、インド、中南米）の市場規模、市場予測、関連企業情報な...
  • 世界の転移性骨がんの薬物治療市場：市場規模・現状・予測世界の転移性骨がんの薬物治療市場：市場規模・現状・予測 Bone metastasis occurs when cancer cells spread from their original site to a bone. Nearly all types ofcancer can spread (metastasize) to the bones. But some types of cancer are particularly likely to spread to bone, including breast cancer and prostatecancerIn 2018, the global Metastatic Bones Canc…
  • 世界の転移性乳がんの治療市場：市場規模・現状・予測世界の転移性乳がんの治療市場：市場規模・現状・予測 Metastatic breast cancer is an advanced stage of breast cancer. It involves cases in which breast cancer has spread to the other parts of the body. Some of the most common organs which are affected by metastatic breast cancer are brain, liver, bones and lungs. It is also known as stage IV breast can…
  • 世界の転移性骨疾患市場：市場規模・現状・予測世界の転移性骨疾患市場：市場規模・現状・予測 Metastatic bone disease can be quite agonizing to patients, both emotionally and financially, when they discover that their cancer has reached an advanced stage, thereby diminishing their chance of survival and adding to the treatment costs. In 2018, the global Metastatic Bone Disease market size wa…
  • 世界の転移性結腸直腸がん手術市場：市場規模・現状・予測世界の転移性結腸直腸がん手術市場：市場規模・現状・予測 Colorectal cancer is the third most common type cancer and represents 9.7% of total cancer cases across the globe. According to American Cancer Society colorectal cancer is treatable and curable when it is localized to the bowel. However, colorectal cancer cancers that have spread to other body part…
  • 世界の転移性大腸がんの治療市場：市場規模・現状・予測世界の転移性大腸がんの治療市場：市場規模・現状・予測 Colorectal cancer is the third most common type cancer and represents 9.7% of total cancer cases across the globe. According to American Cancer Society colorectal cancer is treatable and curable when it is localized to the bowel. However, colorectal cancer cancers that have spread to other body part…